Apyx Medical Corp — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2020-05-13

Reporting Person: Goodwin Charles D. II (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-13	Common Stock	P	28250	$3.299	Acquired	28250	Direct

Footnotes

F1: Average price of shares purchased on the open market on May 13, 2020, ranging from $3.06 to $3.33 per share.